- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8876
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,876 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
WAYS | SEK 15.84 | -8.9% | -44.8% | SEK 127.8m | SEK 36.50 | PS1x | E113.3% | 0% | Tech | ||
NEWBRY | SEK 3.42 | -2.3% | -9.3% | SEK 83.0m | SEK 8.00 | PS2.3x | E130.0% | n/a | Pharmaceuticals & Biotech | ||
RMDA | ج.م3.39 | -1.2% | 101.9% | ج.م5.1b | ج.م5.02 | PE19.2x | E30.7% | 2.0% | Pharmaceuticals & Biotech | ||
FWRY | ج.م8.65 | -1.3% | 47.6% | ج.م29.5b | ج.م11.67 | PE23.8x | E27.4% | n/a | Diversified Financials | ||
AGP | €6.43 | -0.8% | 14.4% | €111.3m | €12.85 | PE16.4x | E22.1% | n/a | Capital Goods | ||
RHM | €613.20 | -0.9% | 115.6% | €26.6b | €721.93 | PE38.9x | E29.9% | 0.9% | Capital Goods | ||
ACE | SEK 3.10 | -6.9% | -15.9% | SEK 297.9m | SEK 8.25 | PB2.8x | E47.2% | n/a | Pharmaceuticals & Biotech | ||
PRL | CA$33.63 | -7.9% | 159.7% | CA$1.4b | CA$44.28 | PE20.8x | E37.6% | 1.8% | Diversified Financials | ||
AXSM | US$90.67 | -7.2% | 28.5% | US$4.5b | US$130.47 | PS13x | E72.5% | n/a | Pharmaceuticals & Biotech | ||
TVTX | US$16.86 | -9.7% | 102.2% | US$1.5b | US$27.40 | PS7.2x | E72.5% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$8.29 | -6.2% | 74.7% | US$452.6m | US$20.00 | PS18.1x | E73.5% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$54.76 | -5.9% | 86.1% | US$18.1b | US$59.48 | PE125.3x | E29.4% | n/a | Consumer Durables | ||
ALNY | US$237.92 | -6.4% | 32.9% | US$31.8b | US$299.11 | PS14.6x | E70.3% | n/a | Pharmaceuticals & Biotech | ||
ALKT | US$37.94 | -4.6% | 62.0% | US$3.9b | US$44.60 | PS12.1x | E98.6% | n/a | Software | ||
SRPT | US$120.25 | -4.1% | 33.2% | US$12.0b | US$183.60 | PE94.3x | E42.5% | n/a | Pharmaceuticals & Biotech | ||
EH | US$13.94 | -9.0% | -11.5% | US$924.6m | US$24.22 | PS18.4x | E81.5% | n/a | Capital Goods | ||
CRDO | US$66.46 | -2.9% | 240.6% | US$11.1b | US$73.54 | PS45.3x | E66.3% | n/a | Semiconductors | ||
NVDA | US$128.91 | -7.5% | 167.9% | US$3.2t | US$172.38 | PE50.1x | E25.1% | 0.03% | Semiconductors | ||
CDR | zł191.90 | -1.9% | 65.4% | zł19.2b | zł145.78 | PE43.6x | E27.0% | 0.5% | Media | ||
ARES | US$169.22 | -7.3% | 48.2% | US$55.8b | US$181.00 | PE79x | E38.5% | 2.2% | Diversified Financials | ||
TGTX | US$31.07 | -1.8% | 80.5% | US$4.8b | US$40.75 | PS16.8x | E57.0% | n/a | Pharmaceuticals & Biotech | ||
A257720 | ₩31,750.00 | 11.8% | 291.5% | ₩1.9t | ₩56,750.00 | PE19.6x | E41.7% | n/a | Retail | ||
BTR | AU$0.02 | -9.1% | 33.3% | AU$142.7m | AU$0.052 | PS135.3x | E84.5% | n/a | Materials | ||
002827 | CN¥31.56 | -0.9% | 96.0% | CN¥8.7b | n/a | PE69.4x | E46.7% | 0.5% | Materials |